These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38572639)
1. SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension. Waxman AB; Systrom DM; Manimaran S; de Oliveira Pena J; Lu J; Rischard FP Circ Heart Fail; 2024 May; 17(5):e011227. PubMed ID: 38572639 [TBL] [Abstract][Full Text] [Related]
2. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. Hoeper MM; Badesch DB; Ghofrani HA; Gibbs JSR; Gomberg-Maitland M; McLaughlin VV; Preston IR; Souza R; Waxman AB; Grünig E; Kopeć G; Meyer G; Olsson KM; Rosenkranz S; Xu Y; Miller B; Fowler M; Butler J; Koglin J; de Oliveira Pena J; Humbert M; N Engl J Med; 2023 Apr; 388(16):1478-1490. PubMed ID: 36877098 [TBL] [Abstract][Full Text] [Related]
3. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. Humbert M; McLaughlin V; Gibbs JSR; Gomberg-Maitland M; Hoeper MM; Preston IR; Souza R; Waxman A; Escribano Subias P; Feldman J; Meyer G; Montani D; Olsson KM; Manimaran S; Barnes J; Linde PG; de Oliveira Pena J; Badesch DB; N Engl J Med; 2021 Apr; 384(13):1204-1215. PubMed ID: 33789009 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Macitentan in Patients With Eisenmenger Syndrome. Gatzoulis MA; Landzberg M; Beghetti M; Berger RM; Efficace M; Gesang S; He J; Papadakis K; Pulido T; Galiè N; Circulation; 2019 Jan; 139(1):51-63. PubMed ID: 30586694 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy. Claessen G; La Gerche A; Dymarkowski S; Claus P; Delcroix M; Heidbuchel H J Am Heart Assoc; 2015 Mar; 4(3):e001602. PubMed ID: 25801760 [TBL] [Abstract][Full Text] [Related]
6. A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial. Elinoff JM; Rame JE; Forfia PR; Hall MK; Sun J; Gharib AM; Abd-Elmoniem K; Graninger G; Harper B; Danner RL; Solomon MA Trials; 2013 Apr; 14():91. PubMed ID: 23547564 [TBL] [Abstract][Full Text] [Related]
7. Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension. Tobita K; Goda A; Teruya K; Nishida Y; Takeuchi K; Kikuchi H; Inami T; Kohno T; Tashiro S; Yamada S; Satoh T; Soejima K J Am Heart Assoc; 2023 Jun; 12(11):e026890. PubMed ID: 37260024 [TBL] [Abstract][Full Text] [Related]
8. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. Ehlken N; Lichtblau M; Klose H; Weidenhammer J; Fischer C; Nechwatal R; Uiker S; Halank M; Olsson K; Seeger W; Gall H; Rosenkranz S; Wilkens H; Mertens D; Seyfarth HJ; Opitz C; Ulrich S; Egenlauf B; Grünig E Eur Heart J; 2016 Jan; 37(1):35-44. PubMed ID: 26231884 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study. Huo Y; Jing ZC; Zeng XF; Liu JM; Yu ZX; Zhang GC; Li Y; Wang Y; Ji QS; Zhu P; Wu BX; Zheng Y; Wang PP; Li J BMC Cardiovasc Disord; 2016 Oct; 16(1):201. PubMed ID: 27770771 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis. Li M; Jing ZC; Li Y; Huo Y; Yu Z; Zhang G; Zhu P; Liu J; Ji Q; Wu B; Zhong J; Wang P; Zhu W; Zeng X BMC Cardiovasc Disord; 2020 Jul; 20(1):339. PubMed ID: 32680480 [TBL] [Abstract][Full Text] [Related]
11. The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension. Liao K; Mackenzie H; Ait-Oudhia S; Manimaran S; Zeng Y; Akers T; Yun T; de Oliveira Pena J Clin Pharmacol Ther; 2024 Mar; 115(3):478-487. PubMed ID: 38012534 [TBL] [Abstract][Full Text] [Related]
12. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial. Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860 [TBL] [Abstract][Full Text] [Related]
13. Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension. Surie S; Reesink HJ; Marcus JT; van der Plas MN; Kloek JJ; Vonk-Noordegraaf A; Bresser P Clin Cardiol; 2013 Nov; 36(11):698-703. PubMed ID: 24037998 [TBL] [Abstract][Full Text] [Related]